Authors: Zhong, Robert; Platt, Jeffrey L

Source: Expert Opinion on Biological Therapy, Volume 5, Number 11, 1 November 2005 , pp. 1415-1420(6)

Publisher: Informa Healthcare

Abstract:

The transplantation of animal organs into humans as a way of treating organ failure has been pursued for 100 years. Clinical xenotransplantation, as such, has always failed because the transplanted organ is rejected by the recipient. Recent advances in transplant immunology have revealed some mechanisms underlying the rejection of xenografts, and these discoveries have sparked efforts to use genetic engineering of animals and therapeutics directed at the recipient to overcome this problem. This paper reviews the current understanding of the mechanisms of xenograft rejection and efforts to o­vercome rejection and other hurdles.

Keywords: acute vascular rejection; genetic engineering; graft rejection; organ transplantation; xenotransplantation

Document Type: Editorial

DOI: http://dx.doi.org/10.1517/14712598.5.11.1415

Publication date: 2005-11-01

More about this publication?

• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Organic Chemistry ,  Oncology
• By this author: Zhong, Robert ;  Platt, Jeffrey L

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers